Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 9/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.53 |
| ▸ | HPGD | P15428 | 7/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | TACR2 | P21452 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30317585 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL30317632 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL2945520 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL10497454 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL30317637 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL8373569 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL10497561 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL10497979 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL5053914 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA | |
| SCHEMBL2941799 | 1.00 | FDPS (0.63) | FDPSMAPTSMN1; SMN2NPSR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2460855-A2 | Oxygen scavenging compositions and packaging comprising said compositions | Constar International Inc. (US) | 2012-06-06 | — | — | EP | claimed |
| US-20090278087-A1 | Oxygen Scavenging Compositions and Packaging Comprising Said Compositions | CONSTAR INTERNATIONAL, INC (US) | 2009-11-12 | — | — | US | claimed |
| EP-1848659-A2 | OXYGEN SCAVENGING COMPOSITIONS AND PACKAGING COMPRISING SAID COMPOSITIONS | Constar International Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2006088889-A2 | OXYGEN SCAVENGING COMPOSITIONS AND PACKAGING COMPRISING SAID COMPOSITIONS | CONSTAR INTERNATIONAL, INC. (US) | 2006-08-24 | — | — | WO | claimed |
| US-20060180790-A1 | polyesters; melt polymerization; packaging | CONSTAR INTERNATIONAL INC. (US) | 2006-08-17 | — | — | US | claimed |
| US-8721920-B2 | Oxygen scavenging compositions and packaging comprising said compositions | PLASTIPAK PACKAGING, INC. (US) | 2014-05-13 | — | — | US | disclosed |
| EP-1848659-B1 | OXYGEN SCAVENGING COMPOSITIONS AND PACKAGING COMPRISING SAID COMPOSITIONS | CONSTAR INT INC (US) | 2013-03-20 | — | — | EP | disclosed |
| EP-2460855-A2 | Oxygen scavenging compositions and packaging comprising said compositions | Constar International Inc. (US) | 2012-06-06 | — | — | EP | disclosed |
| US-20100154361-A1 | Oxygen Scavenging Compositions And Packaging Comprising Said Compositions | CONSTAR INTERNATIONAL, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| US-7691290-B2 | polyesters; melt polymerization; packaging | CONSTAR INTERNATIONAL INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090278087-A1 | Oxygen Scavenging Compositions and Packaging Comprising Said Compositions | CONSTAR INTERNATIONAL, INC (US) | 2009-11-12 | — | — | US | disclosed |
| EP-1848659-A4 | OXYGEN SCAVENGING COMPOSITIONS AND PACKAGING COMPRISING SAID COMPOSITIONS | CONSTAR INT INC (US) | 2009-08-12 | — | — | EP | disclosed |
| US-20060180790-A1 | polyesters; melt polymerization; packaging | CONSTAR INTERNATIONAL INC. (US) | 2006-08-17 | — | — | US | disclosed |
| EP-0664282-B1 | Biaryl phospholipase A2 inhibitors | BRISTOL MYERS SQUIBB CO (US) | 1997-10-22 | — | — | EP | disclosed |
| EP-0629604-B1 | Alicyclic phospholipase A2 inhibitors | BRISTOL MYERS SQUIBB CO (US) | 1997-04-16 | — | — | EP | disclosed |
| EP-0664282-A1 | Biaryl phospholipase A2 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-07-26 | — | — | EP | disclosed |
| US-5436369-A | Alicyclic phospholipase A2 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-07-25 | — | — | US | disclosed |
| US-5391817-A | Antiinflammatory agents | BRISTOL-MYERS SQUIBB (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0629604-A2 | Alicyclic phospholipase A2 inhibitors | Bristol-Myers Company (US) | 1994-12-21 | — | — | EP | disclosed |
| EP-0328669-A1 | CHALCONE DERIVATIVE COMPOUNDS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090278087-A1 | Oxygen Scavenging Compositions and Packaging Comprising Said Compositions | LPO, GPX4, PRDX3 | FDPS 3879/4885MAPT 3540/4885SMN1; SMN2 651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.